Filtros de búsqueda

Lista de obras de

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

artículo científico publicado en 2010

A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.

artículo científico publicado en 2011

Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma

artículo científico publicado en 2010

Absolute lymphocyte count at day 29 of treatment is a powerful predictor of outcome in multiple myeloma

scientific article published on 23 October 2014

An analysis of the false negative rate of minimal residual disease measurement by multiparameter flow cytometry in multiple myeloma

scientific article published on 20 September 2019

Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma

artículo científico publicado en 2011

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report

artículo científico publicado en 2017

Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma

artículo científico publicado en 2019

Gender disparities in the tumor genetics and clinical outcome of multiple myeloma

artículo científico publicado en 2011

High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma.

artículo científico publicado en 2010

Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma

scientific article published on 02 July 2019

Liposomal cytarabine in cerebrospinal fluid.

artículo científico publicado en 2008

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

artículo científico publicado en 2011

Novel drugs in myeloma: harnessing tumour biology to treat myeloma.

artículo científico publicado en 2011

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results

artículo científico publicado en 2014

Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.

artículo científico publicado en 2013

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. ⬇️

artículo científico publicado en 2016

The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study.

artículo científico publicado en 2010

The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapy

artículo científico publicado en 2011

The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience

artículo científico publicado en 2016

The impact of extramedullary disease at presentation on the outcome of myeloma

artículo científico publicado en 2009

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda